IPG Photonics (NASDAQ:IPGP) Upgraded at Wall Street Zen

IPG Photonics (NASDAQ:IPGP) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.

IPGP has been the topic of several other research reports. Weiss Ratings reissued a “sell (d+)” rating on shares of IPG Photonics in a report on Monday, December 29th. Raymond James Financial lowered IPG Photonics from a “strong-buy” rating to an “outperform” rating and increased their price target for the company from $97.00 to $180.00 in a research note on Friday, February 13th. Benchmark reaffirmed a “hold” rating on shares of IPG Photonics in a research note on Wednesday, December 10th. Stifel Nicolaus boosted their price objective on IPG Photonics from $92.00 to $165.00 and gave the stock a “buy” rating in a research note on Friday, February 13th. Finally, Zacks Research upgraded IPG Photonics from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 15th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, IPG Photonics has an average rating of “Moderate Buy” and an average price target of $131.40.

IPG Photonics Stock Down 6.0%

Shares of IPGP opened at $115.36 on Friday. The firm has a market capitalization of $4.87 billion, a PE ratio of 155.89, a P/E/G ratio of 3.01 and a beta of 0.95. The firm has a 50-day moving average price of $111.43 and a 200 day moving average price of $91.54. IPG Photonics has a 52-week low of $48.59 and a 52-week high of $155.82.

IPG Photonics (NASDAQ:IPGP) last released its quarterly earnings results on Thursday, February 12th. The semiconductor company reported $0.46 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.21. The company had revenue of $274.47 million for the quarter, compared to the consensus estimate of $249.58 million. IPG Photonics had a net margin of 3.10% and a return on equity of 2.89%. IPG Photonics’s revenue was up 17.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.18 EPS. IPG Photonics has set its Q1 2026 guidance at 0.100-0.400 EPS. On average, equities analysts expect that IPG Photonics will post 1.54 EPS for the current year.

Insider Activity at IPG Photonics

In other news, major shareholder Fibre Devices Ltd Ip sold 13,381 shares of IPG Photonics stock in a transaction dated Wednesday, January 21st. The stock was sold at an average price of $81.52, for a total transaction of $1,090,819.12. Following the completion of the sale, the insider directly owned 6,593,169 shares in the company, valued at $537,475,136.88. The trade was a 0.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Valentin Gapontsev Trust I sold 7,952 shares of the stock in a transaction that occurred on Thursday, January 15th. The stock was sold at an average price of $80.10, for a total value of $636,955.20. Following the completion of the transaction, the insider owned 6,793,099 shares in the company, valued at $544,127,229.90. This represents a 0.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 201,484 shares of company stock worth $15,646,382. 39.50% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On IPG Photonics

Several institutional investors and hedge funds have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in IPG Photonics by 20.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 39,024 shares of the semiconductor company’s stock worth $2,541,000 after buying an additional 6,741 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of IPG Photonics by 0.9% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 87,469 shares of the semiconductor company’s stock worth $5,523,000 after buying an additional 744 shares during the last quarter. Jane Street Group LLC boosted its stake in shares of IPG Photonics by 79.4% during the 1st quarter. Jane Street Group LLC now owns 122,105 shares of the semiconductor company’s stock worth $7,710,000 after acquiring an additional 54,026 shares in the last quarter. PNC Financial Services Group Inc. boosted its stake in shares of IPG Photonics by 8.9% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,813 shares of the semiconductor company’s stock worth $124,000 after acquiring an additional 148 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in shares of IPG Photonics by 7.5% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,776 shares of the semiconductor company’s stock valued at $465,000 after acquiring an additional 470 shares during the last quarter. Institutional investors and hedge funds own 93.79% of the company’s stock.

About IPG Photonics

IPG Photonics Corporation is a global leader in the design and manufacture of high-performance fiber lasers and amplifiers used in industrial, medical, scientific, and telecommunications applications. The company’s core products include ytterbium and erbium fiber lasers, diode lasers, and fiber amplifiers that deliver high power and efficiency for precision cutting, welding, marking, and engraving. IPG’s systems are engineered to optimize process speed, reliability, and energy consumption, making them a preferred choice for advanced manufacturing environments.

In addition to stand-alone laser sources, IPG offers turnkey laser systems and integrated solutions tailored to sectors such as automotive, electronics, aerospace, additive manufacturing, and life sciences.